Drug Trial Radar · NCT07908641
Comparing the Extent to Which Apremilast is Made Available in the Body After Administration as an Extended-release or Immediate-release Formulation
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
114
Planned (sponsor's estimate)
Start
Nov 18, 2026
Primary completion
Jan 10, 2027
Study completion Jan 10, 2027
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Nov 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main objective of this study is to compare the relative bioavailability, safety, and tolerability of extended-release and immediate-release apremilast formulations in healthy participants.
Conditions
- Psoriasis
- Arthritis, Psoriatic
- Oral Ulcer
Interventions
Apremilast XRDrug
Participants will receive apremilast XR orally.
Apremilast IRDrug
Participants will receive apremilast IR orally .
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Plasma Concentration-time Curve (AUC) from Time Zero extrapolated to Infinity (AUCinf) of Apremilast.Time frame: Pre-dose on Day 1 through Day 4 of each treatment period
- Area Under the Plasma Concentration-time Curve from Time Zero to Time of Last Quantifiable Concentration (AUClast) of ApremilastTime frame: Pre-dose on Day 1 through Day 4 of each treatment period
- Maximum Observed Plasma Concentration (Cmax) of Apremilast.Time frame: Pre-dose on Day 1 through Day 4 of each treatment period
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Fortrea Clinical Research Unit - Daytona Beach
Daytona Beach, Florida · Recruiting
Fortrea Clinical Research Unit - Dallas
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.